Shanthi V (V Shanthi, Shanthi Veerappapillai)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 16

Top Topics

Diabetic Nephropathy

Molecular Docking

Small Cell Lung Cancer

Inflammatory Response

Top Venues

Medical oncology (Northwood, London, England)

Cell biochemistry and biophysics

Biotechnology and applied biochemistry

Journal of biomolecular structure & dynamics

This page only lists publications with an associated author ORCID identifier.

Publications

Muthu Kumar Thirunavukkarasu, Priyanka Ramesh, Karuppasamy Ramanathan, Shanthi V
Transcriptome profiling and metabolic pathway analysis towards reliable biomarker discovery in early-stage lung cancer. Journal of applied genetics (2024)
Priyanga Paranthaman, Shanthi V
Design of a potential Sema4A-based multi-epitope vaccine to combat triple-negative breast cancer: an immunoinformatic approach. Medical oncology (Northwood, London, England) 40 (3) (2023)
Priyanga Paranthaman, Shanthi V
Design of a potential Sema4A-based multi-epitope vaccine to combat triple-negative breast cancer: an immunoinformatic approach. Medical oncology (Northwood, London, England) 40 (3) (2023)
Priyanga Paranthaman, Shanthi V
Design of a potential Sema4A-based multi-epitope vaccine to combat triple-negative breast cancer: an immunoinformatic approach. Medical oncology (Northwood, London, England) 40 (3) (2023)
Priyanga Paranthaman, Shanthi V
Design of a potential Sema4A-based multi-epitope vaccine to combat triple-negative breast cancer: an immunoinformatic approach. Medical oncology (Northwood, London, England) 40 (3) (2023)
Muthu Kumar Thirunavukkarasu, Shanthi V, Karuppasamy Ramanathan
Sequential virtual screening collaborated with machine-learning strategies for the discovery of precise medicine against non-small cell lung cancer. Journal of biomolecular structure & dynamics (2023)
Priyanga Paranthaman, Shanthi V
Design of a potential Sema4A-based multi-epitope vaccine to combat triple-negative breast cancer: an immunoinformatic approach. Medical oncology (Northwood, London, England) 40 (3) (2023)
Priyanka Ramesh, Ramanathan Karuppasamy, Shanthi V
Machine learning driven drug repurposing strategy for identification of potential RET inhibitors against non-small cell lung cancer. Medical oncology (Northwood, London, England) 40 (1) (2022)
Priyanka Ramesh, Ramanathan Karuppasamy, Shanthi V
Machine learning driven drug repurposing strategy for identification of potential RET inhibitors against non-small cell lung cancer. Medical oncology (Northwood, London, England) 40 (1) (2022)
Priyanka Ramesh, Ramanathan Karuppasamy, Shanthi V
Machine learning driven drug repurposing strategy for identification of potential RET inhibitors against non-small cell lung cancer. Medical oncology (Northwood, London, England) 40 (1) (2022)
Priyanka Ramesh, Ramanathan Karuppasamy, Shanthi V
Machine learning driven drug repurposing strategy for identification of potential RET inhibitors against non-small cell lung cancer. Medical oncology (Northwood, London, England) 40 (1) (2022)
Muthu Kumar T, Rohini K, Nivya James, Shanthi V, Karuppasamy Ramanathan
Discovery of potent Covid-19 main protease inhibitors using integrated drug-repurposing strategy. Biotechnology and applied biochemistry 68 (4) (2021)
Saranyadevi Subburaj, Tanvi Anand Nagrale, Mohd Mustufa Khan, Nivya James, Ramanathan Karuppasamy, Shanthi V
Discovery of anaplastic lymphoma kinase inhibitors from natural product library: A holistic in silico approach. Biotechnology and applied biochemistry (2020)
K Rohini, K Ramanathan, Shanthi V
Multi-Dimensional Screening Strategy for Drug Repurposing with Statistical Framework-A New Road to Influenza Drug discovery. Cell biochemistry and biophysics 77 (4) (2019)
K Rohini, Shanthi V
Hyphenated 3D-QSAR statistical model-drug repurposing analysis for the identification of potent neuraminidase inhibitor. Cell biochemistry and biophysics 76 (3) (2018)
J Nisha, Shanthi V
Characterization of Ofloxacin Interaction with Mutated (A91V) Quinolone Resistance Determining Region of DNA Gyrase in Mycobacterium Leprae through Computational Simulation. Cell biochemistry and biophysics 76 (1-2) (2017)